Skip to main content

This startup might finally cure sickle cell disease—after a century of racist neglect

By Forbes  
   July 13, 2020

The painful blood disorder, which mostly affects Black people, is just one of thousands of rare diseases that could be cured by Beam Therapeutics' revolutionary gene editing technology.

Full story

Get the latest on healthcare leadership in your inbox.